EX-21.1 2 ibrx-20221231x10kexhibit211.htm EX-21.1 Document
Exhibit 21.1
SUBSIDIARIES OF IMMUNITYBIO, INC.

Name of SubsidiaryJurisdiction of
Organization
Percentage of
Voting Securities
Owned Directly
or Indirectly by
ImmunityBio, Inc.
Infacell Therapeutics, Inc.Delaware100.0%
Inex Bio, Inc.Republic of Korea100.0%
NantCell, Inc.Delaware100.0%
Etubics CorporationDelaware100.0%
Altor BioScience, LLCDelaware100.0%
Altor BioScience Manufacturing Company, LLCDelaware100.0%
Receptome, Inc.Delaware100.0%
VBC Holdings LLCDelaware92.0%
VivaBioCell, S.p.A.Italy100.0%
GlobeImmune, Inc.Delaware69.1%
Immunotherapy NANTibody, LLCDelaware60.0%
IgDraSol, Inc.Delaware100.0%
MCLR Parent LLCDelaware100.0%
Mariposa Clinic Co LLCDelaware100.0%
Mariposa Lab Co LLCDelaware100.0%
Mariposa Radiology Co LLCDelaware100.0%
AccessBio LLCDelaware50.0%

__________
Note:    All of the subsidiaries shown above are included in our consolidated financial statements. Inactive subsidiaries have not been included in the above list.